Atea Pharmaceuticals, Inc. ( AVIR) - Key Metrics
AVIR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.41 | -$0.46 | -$0.46 |
| 2026Q1 | $0 | -$0.57 | -$0.59 | -$0.59 |
| 2025Q4 | $0 | -$0.57 | -$0.36 | -$0.36 |
| 2025Q3 | $0 | -$0.53 | -$0.51 | -$0.51 |
| 2025Q2 | $0 | -$0.44 | -$0.39 | -$0.39 |
AVIR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.84 |
| 2026Q1 | 0% | -2.36 |
| 2025Q4 | 0% | -1.57 |
| 2025Q3 | 0% | -1.37 |
| 2025Q2 | 0% | -2.05 |
AVIR
Price: $4.32
52 week price:
Earnings Per Share: -2.12 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 884000
Ebitda: -17.0 millionMarket Capitalization: 410.5 million